Medytox Inc. - Net Worth and Insider Trading
Medytox Inc. Net Worth
The estimated net worth of Medytox Inc. is at least $31 Million dollars as of 2025-07-07. Medytox Inc. is the Former 10% Owner of Evolus Inc and owns about 3,381,326 shares of Evolus Inc (EOLS) stock worth over $31 Million. Details can be seen in Medytox Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Medytox Inc. has not made any transactions after 2023-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Medytox Inc.
Medytox Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Medytox Inc. owns 1 companies in total, including Evolus Inc (EOLS) .
Click here to see the complete history of Medytox Inc.’s form 4 insider trades.
Insider Ownership Summary of Medytox Inc.
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
EOLS | Evolus Inc | 2023-10-16 | 10 percent owner |
Medytox Inc. Latest Holdings Summary
Medytox Inc. currently owns a total of 1 stock. Medytox Inc. owns 3,381,326 shares of Evolus Inc (EOLS) as of October 16, 2023, with a value of $31 Million.
Latest Holdings of Medytox Inc.
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EOLS | Evolus Inc | 2023-10-16 | 3,381,326 | 9.27 | 31,344,892 |
Holding Weightings of Medytox Inc.
Medytox Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Medytox Inc. has made a total of 17 transactions in Evolus Inc (EOLS) over the past 5 years, including 8 buys and 9 sells. The most-recent trade in Evolus Inc is the sale of 1,690,663 shares on October 16, 2023, which brought Medytox Inc. around $13 Million.
Insider Trading History of Medytox Inc.
- 1
Medytox Inc. Trading Performance
GuruFocus tracks the stock performance after each of Medytox Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Medytox Inc. is -39.95%. GuruFocus also compares Medytox Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Medytox Inc. within 3 months outperforms 0 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Medytox Inc.'s insider trading performs compared to the benchmark.
Performance of Medytox Inc.
Medytox Inc. Ownership Network
Ownership Network List of Medytox Inc.
Ownership Network Relation of Medytox Inc.

Medytox Inc. Owned Company Details
What does Evolus Inc do?
Who are the key executives at Evolus Inc?
Medytox Inc. is the 10 percent owner of Evolus Inc. Other key executives at Evolus Inc include director & See Remarks David Moatazedi , Chief Financial Officer Sandra Beaver , and See Remarks Rui Avelar .
Evolus Inc (EOLS) Insider Trades Summary
Over the past 18 months, Medytox Inc. made no insider transaction in Evolus Inc (EOLS). Other recent insider transactions involving Evolus Inc (EOLS) include a net sale of 861,812 shares made by David Moatazedi , a net sale of 30,268 shares made by Sandra Beaver , and a net sale of 66,406 shares made by Rui Avelar .
In summary, during the past 3 months, insiders sold 153,571 shares of Evolus Inc (EOLS) in total and bought 20,000 shares, with a net sale of 133,571 shares. During the past 18 months, 1,039,333 shares of Evolus Inc (EOLS) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 1,019,333 shares.
Evolus Inc (EOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evolus Inc Insider Transactions
Medytox Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Medytox Inc.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Medytox Inc.'s mailing address is: Cheogju-si M5 28126.